-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PXVX-0317 in Chikungunya Fever
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PXVX-0317 in Chikungunya Fever report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PXVX-0317 in Chikungunya FeverDrug Details:PXVX-0317 is under development for the prevention of chikungunya...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Alprostadil in Acute Renal Failure (ARF) (Acute Kidney Injury)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Alprostadil in Acute Renal Failure (ARF) (Acute Kidney Injury) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Alprostadil in Acute Renal Failure (ARF) (Acute Kidney...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ProTmune in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ProTmune in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)Drug Details:ProTmune is under development for the prevention...
-
Sector Analysis
Taiwan Solar PV Market Analysis by Size, Installed Capacity, Power Generation, Regulations, Key Players and Forecast to 2035
Taiwan Solar PV Market Overview In Taiwan’s renewable power generation mix, solar PV was the dominant source in 2022, followed by biopower, and offshore wind power. The cumulative installed capacity for solar PV in the country was 9,723.8MW which will grow at a CAGR of more than 12% during 2022-2035. Crystalline PV modules were the most preferred for solar photovoltaic (PV) installations across the country. Taiwan Solar PV Market Outlook (2022-2035) Buy the Full Report For more insights into the...
-
Company Profile
E2open Parent Holdings Inc – Company Profile
E2open Parent Holdings Inc (E2open) provider of cloud-based, end-to-end SCM and orchestration software. The company provides supply chain management software solutions including a suite of collaborative supply chain solutions. It offers products such as E2 process management, E2 planning and response, E2 cloud connectivity and E2 analytics. E2open provides SaaS-based demand-supply network solutions. E2open offers solutions for sourcing and procurement, logistics, operations, demand signal management, supply chain management, IT, transportation and customer fulfillment. The company caters to aerospace and defense,...
Add to Basket -
Company Profile
Azul SA – Company Profile
Azul SA (Azul) is a low-cost carrier passenger transportation services provider. The company operates and manages various fleets and offers scheduled flights in Brazil and flies to selected international destinations, including Fort Lauderdale, Orlando and Lisbon, and Porto. Its fleet of aircraft comprises of Embraer aircraft E-190, E-195, and E-195-E2, ATR aircraft ATR 72, Airbus aircraft A320neo, A330neo, and Boeing 737 Freighter. The company operates through hubs in Campinas at Viracopos airport, Confins airport in Belo Horizonte, and Recife airport,...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CNP-104
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry CNP-104 Drug Details CNP-104 is under development for the treatment of primary biliary cholangitis....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – LX-1001
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry LX-1001 Drug Details LX-1001 is under development for the treatment of Alzheimer's disease. It...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – JVGL-1
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry JVGL-1 Drug Details JVGL-1 is under development for the treatment of open-angle glaucoma and...
-
Product Insights
Net Present Value Model: PXVX-0317
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model PXVX-0317 Drug Details PXVX-0317 is under...